2024-12-01 2025-11-30 false Capium Accounts Production 1.1 13774090 2024-12-01 2025-11-30 13774090 bus:AbridgedAccounts 2024-12-01 2025-11-30 13774090 bus:FRS102 2024-12-01 2025-11-30 13774090 bus:AuditExempt-NoAccountantsReport 2024-12-01 2025-11-30 13774090 bus:SmallCompaniesRegimeForAccounts 2024-12-01 2025-11-30 13774090 bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 13774090 2024-12-01 2025-11-30 13774090 2025-11-30 13774090 bus:RegisteredOffice 2024-12-01 2025-11-30 13774090 core:WithinOneYear 2025-11-30 13774090 core:AfterOneYear 2025-11-30 13774090 1 2024-12-01 2025-11-30 13774090 bus:Director1 2024-12-01 2025-11-30 13774090 bus:Director1 2025-11-30 13774090 bus:Director1 2023-12-01 2024-11-30 13774090 2023-12-01 13774090 bus:LeadAgentIfApplicable 2024-12-01 2025-11-30 13774090 2023-12-01 2024-11-30 13774090 2024-11-30 13774090 core:WithinOneYear 2024-11-30 13774090 core:AfterOneYear 2024-11-30 13774090 bus:EntityAccountantsOrAuditors 2023-12-01 2024-11-30 13774090 bus:OrdinaryShareClass1 2024-12-01 2025-11-30 13774090 bus:OrdinaryShareClass1 2025-11-30 13774090 bus:OrdinaryShareClass1 2023-12-01 2024-11-30 13774090 bus:OrdinaryShareClass1 2024-11-30 13774090 core:PlantMachinery 2024-12-01 2025-11-30 13774090 core:PlantMachinery 2025-11-30 13774090 core:PlantMachinery 2024-11-30 13774090 core:ComputerEquipment 2024-12-01 2025-11-30 13774090 core:ComputerEquipment 2025-11-30 13774090 core:ComputerEquipment 2024-11-30 13774090 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-11-30 13774090 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-11-30 13774090 core:CostValuation core:Non-currentFinancialInstruments 2025-11-30 13774090 core:CostValuation core:Non-currentFinancialInstruments 2024-11-30 13774090 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-11-30 13774090 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-11-30 13774090 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-11-30 13774090 core:Non-currentFinancialInstruments 2025-11-30 13774090 core:Non-currentFinancialInstruments 2024-11-30 13774090 core:ShareCapital 2025-11-30 13774090 core:ShareCapital 2024-11-30 13774090 core:RetainedEarningsAccumulatedLosses 2025-11-30 13774090 core:RetainedEarningsAccumulatedLosses 2024-11-30 13774090 dpl:Item1 2024-12-01 13774090 dpl:Item1 2025-11-30 13774090 dpl:Item1 2023-12-01 13774090 dpl:Item1 2024-11-30 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 13774090
IMPLANTOLOGY ADVANCED CLINIC LTD
Abridged Accounts
Period of accounts Start date: 01 December 2024 End date: 30 November 2025

IMPLANTOLOGY ADVANCED CLINIC LTD Contents Page For the year ended 30 November 2025
Statement of Financial Position | 1
Notes to the Financial Statements | 2

IMPLANTOLOGY ADVANCED CLINIC LTD Statement of Financial Position As at 30 November 2025
| Notes | 2025 £ |  | 2024 £
--- | --- | --- | --- | ---
Fixed assets |  |  |
Tangible fixed assets | 3 | 4,882 |  | 3,583
|  | 4,882 |  | 3,583
Current assets |  |  |
Cash at bank and in hand |  | 3,161 |  | 4,181
Creditors: amount falling due within one year |  | (7,933) |  | (13,996)
Net current assets |  | (4,772) |  | (9,815)
Total assets less current liabilities |  | 110 |  | (6,232)
Net assets |  | 110 |  | (6,232)
Capital and reserves |  |  |
Called up share capital | 4 | 100 |  | 100
Profit and loss account |  | 10 |  | (6,332)
Shareholders' funds |  | 110 |  | (6,232)
For the year ended 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Director's responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A). The financial statements were approved by the director on 05 August 2026 and were signed by:
------------------------------- CARVALHO PACHECO Christiane CARVALHO PACHECO Director
1

IMPLANTOLOGY ADVANCED CLINIC LTD Notes to the Abridged Financial Statements For the year ended 30 November 2025
General Information IMPLANTOLOGY ADVANCED CLINIC LTD is a private company, limited by shares, registered in , registration number 13774090, registration address 46 Elbe Street, SW6 2QP. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies. The financial statements are prepared in sterling which is the functional currency of the company. Going concern basis The directors believe that the company is experiencing good levels of sales growth and profitability, and that it is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements. Turnover Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts. Taxation Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Current and deferred tax assets and liabilities are not discounted Dividends Proposed dividends are only included as liabilities in the statement of financial position when their payment has been approved by the shareholders prior to the statement of financial position date. Tangible fixed assets Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Plant and Machinery | 18% Reducing Balance
Computer Equipment | 18% Reducing Balance
2. | Average number of employees Average number of employees during the year was 2 (2024 : 2).
3. | Tangible fixed assets
Cost or valuation | Plant and Machinery |  | Computer Equipment |  | Total
| £ |  | £ |  | £
At 01 December 2024 | 1,335 |  | 5,330 |  | 6,665
Additions | - |  | 2,518 |  | 2,518
Disposals | - |  | - |  | -
At 30 November 2025 | 1,335 |  | 7,848 |  | 9,183
Depreciation
At 01 December 2024 | 481 |  | 2,601 |  | 3,082
Charge for year | 170 |  | 1,049 |  | 1,219
On disposals | - |  | - |  | -
At 30 November 2025 | 651 |  | 3,650 |  | 4,301
Net book values
Closing balance as at 30 November 2025 | 684 |  | 4,198 |  | 4,882
Opening balance as at 01 December 2024 | 854 |  | 2,729 |  | 3,583
4. | Share Capital
Allotted, called up and fully paid | 2025 £ |  | 2024 £
--- | --- | --- | ---
100 Ordinary shares of £1.00 each | 100 |  | 100
| 100 |  | 100
2